Wes Wheeler

Wes Wheeler

Wes Wheeler has served as a director since February 2024. Mr. Wheeler serves as Chief Executive Officer and board member of LabConnect, Inc. Mr.  Wheeler previously served as president of UPS Healthcare from 2020 to 2023 and chief executive officer of its subsidiary Marken LLP from 2011 to 2019, chief executive officer, president and director of Patheon (now a Thermo Fisher Scientific company) from 2007 to 2010, and president, R&D and global manufacturing at Valeant Pharmaceuticals 2003 to 2007. Earlier in his career, he held various leadership roles in engineering, marketing, and manufacturing at GlaxoSmithKline and ExxonMobil.

 In addition to the Mallinckrodt Board, Mr. Wheeler currently serves as a director on the boards of various private pharmaceutical companies. Mr. Wheeler also serves on the board of directors of Argenta, an animal health company.

Mr. Wheeler holds a BSME from Worcester Polytechnic Institute and an MBA from California Lutheran University.

Mr. Wheeler’s qualifications to serve on our Board include his more than 40 years of diversified leadership experience in healthcare, including business turnarounds and transformations, manufacturing, marketing, engineering, R&D and supply chain operations.